In response to the COVID-19 Vaccine manufacture programme, CPI need to secure supply of linearised plasmid to help develop a self-amplifying RNA Vaccine. This tender is split into three lots: 1. To generate and validate a MCB for plasmid production, starting with a provided plasmid template in an appropriate strain of E. coli. 2. From the MCB, supply 10g of purified linearised plasmid manufactured according to GMP.(To simplify the tendering process, CPI will free issue the restriction enzyme for linearization to the successful bidder) 3. Provision of the combined services of Lot 1 and 2.
Contract value: 10000000
Published: 26 Jun 2020, Receipt by: 10 Jul 2020
All suppliers that are registered with us receive email notifications of Public Sector tenders related to their area of business.